TNF RECEPTOR 2 AND DISEASE: Autoimmunity and Regenerative Medicine
The regulatory cytokine tumor necrosis factor (TNF) exerts its effects through two receptors: TNFR1 and TNFR2. Defects in TNFR2 signaling are evident in a variety of autoimmune diseases. One new treatment strategy for autoimmune disease is selective destruction of autoreactive T cells by administ...
Main Authors: | Denise Louise Faustman, Miriam eDavis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00478/full |
Similar Items
-
The benefits of clustering in TNF receptor superfamily signaling
by: Éva S. Vanamee, et al.
Published: (2023-08-01) -
Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
by: Lei Bao, et al.
Published: (2003-02-01) -
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
by: Huimin Zou, et al.
Published: (2018-03-01) -
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
by: Roman Fischer, et al.
Published: (2015-03-01) -
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)